|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 32 | 2022 | Employment and Cognitive Improvements in Ocrelizumab-Treated Patients with Relapsing-Remitting Multiple Sclerosis: 96-Week CASTING Study Data | Wiendl, H.; Benedict, R.H.B.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Buffels, R.; Kuenzel, T.; Vermersch, P. | Conference Material | C2 |
| 33 | 2022 | Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180] | DE BROUWER, Edward; BECKER, Thijs; Moreau, Yves; Havrdova, Eva Kubala; Trojano, Maria; Eichau, Sara; Ozakbas, Serkan; Onofrj, Marco; Grammond, Pierre; Kuhle, Jens; Kappos, Ludwig; Sola, Patrizia; Cartechini, Elisabetta; Lechner-Scott, Jeannette; Alroughani, Raed; Gerlach, Oliver; Kalincik, Tomas; Granella, Franco; Grand'Maison, Francois; VAN WIJMEERSCH, Bart; Bergamaschi, Roberto; Sá, Maria José; Soysal, Aysun; Sanchez-Menoyo, Jose Luis; Solaro, Claudio; Boz, Cavit; Iuliano, Gerardo; Buzzard, Katherine; Aguera-Morales, Eduardo; Terzi, Murat; Trivio, Tamara Castillo; Spitaleri, Daniele; Van Pesch, Vincent; Shaygannejad, Vahid; Moore, Fraser; Oreja-Guevara, Celia; Maimone, Davide; Gouider, Riadh; Csepany, Tunde; Ramo-Tello, Cristina; PEETERS, Liesbet | Journal Contribution | A1 |
| 3 | 2022 | Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trial | Vermersch, Patrick; Oreja-Guevara, Celia; Siva, Aksel; VAN WIJMEERSCH, Bart; Wiendl, Heinz; Wuerfel, Jens; Buffels, Regine; Kadner, Karen; Kuenzel, Thomas; Comi, Giancarlo | Journal Contribution | A1 |
| 4 | 2022 | Motor evoked potentials for multiple sclerosis, a multiyear follow-up dataset | YPERMAN, Jan; POPESCU, Veronica; VAN WIJMEERSCH, Bart; BECKER, Thijs; PEETERS, Liesbet | Journal Contribution | A1 |
| 5 | 2022 | A real-world single-centre analysis of the safety and efficacy of cladribine tablets for relapsing multiple sclerosis | AERTS, Sofie; KHAN, Hamza; SEVERIJNS, Deborah; POPESCU, Veronica; PEETERS, Liesbet; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 6 | 2022 | A multi-stakeholder survey on multiple sclerosis multidisciplinary care: The situation in Belgium and lessons for the global community | Van Hijfte, L.; Cambron, M.; Capron, B.; Dachy, B.; Decoo, D.; Dive, D.; Dubois, B.; El Sankari, S.; London, F.; Perrotta, G.; POPESCU, Veronica; Van Pesch, V.; VAN WIJMEERSCH, Bart; Willekens, B.; Laureys, G. | Journal Contribution | M |
| 7 | 2022 | Rapamycin rescues loss-of-function in blood-brain barrier-interacting regulatory T cells | BAETEN, Paulien; HAMAD, Ibrahim; HOEKS, Cindy; Hiltensperger, Michael; VAN WIJMEERSCH, Bart; POPESCU, Veronica; Aly, Lilian; SOMERS, Veerle; Korn, Thomas; KLEINEWIETFELD, Markus; HELLINGS, Niels; BROUX, Bieke | Preprint | O |
| 8 | 2021 | Multicentric motor evoked potentials in multiple sclerosis: a retrospective pilot study | DEKEYSER, Catherine; YPERMAN, Jan; KHAN, Hamza; VAN WIJMEERSCH, Bart; Verhoeven, K.; Cambron, M.; BECKER, Thijs; Laureys, G.; PEETERS, Liesbet | Journal Contribution | M |
| 9 | 2021 | Outcomes in Alemtuzumab-Treated Patients With Thyroid Adverse Events: 6-Year Pooled CARE-MS Data | Dayan, Colin; Lecumberri, Beatriz; Muller, Ilaria; Ganesananthan, Sashiananthan; Hunter, Samuel F.; Selmaj, Krzysztof W.; Hartung, Hans-Peter; Havrdova, Eva K.; LaGanke, Christopher C.; Ziemssen, Tjalf; VAN WIJMEERSCH, Bart; Meuth, Sven G.; Margolin, David H.; Afsar, Salman; Daizadeh, Nadia; Poole, Elizabeth M.; Baker, Darren P.; Senior, Peter A. | Journal Contribution | M |
| 10 | 2021 | Efficacy and safety of ocrelizumab in patients with RRMS with suboptimal response to prior disease-modifying therapies: 3-year data from CASTING and LIBERTO 1-year interim results | VAN WIJMEERSCH, Bart; Comi, G.; Oreja-Guevara, C.; Wiendl, H.; Wuerfel, J.; Buffels, R.; Dirks, P.; Kuenzel, T.; Kadner, K.; Vermersch, P. | Journal Contribution | M |
| 11 | 2021 | Clinical manifestation and perceived symptoms of walking-related performance fatigability in persons with multiple sclerosis | VAN GEEL, Fanny; Bielen, H; THEUNISSEN, Kyra; MOUMDJIAN, Lousin; Van Nieuwenhoven, J; VAN WIJMEERSCH, Bart; MEESEN, Raf; Ramari, C; FEYS, Peter | Journal Contribution | A1 |
| 12 | 2021 | The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies | Andersen, Johanna B.; Lefort, Mathilde; Koch-Henriksen, Nils; Sellebjerg, Finn; Sorensen, Per Soelberg; Christensen, Claudia C. Hilt; Rasmussen, Peter, V; Jensen, Michael B.; Frederiksen, Jette L.; Bramow, Stephan; Mathiesen, Henrik K.; Schreiber, Karen, I; Horakova, Dana; Havrdova, Eva K.; Alroughani, Raed; Izquierdo, Guillermo; Eichau, Sara; Ozakbas, Serkan; Patti, Francesco; Onofrj, Marco; Lugaresi, Alessandra; Terzi, Murat; Grammond, Pierre; Maison, Francois Grand; Yamout, Bassem; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Boz, Cavit; Trojano, Maria; McCombe, Pamela; Slee, Mark; Lechner-Scott, Jeannette; Turkoglu, Recai; Sola, Patrizia; Ferraro, Diana; Granella, Franco; Shaygannejad, Vahid; Prevost, Julie; Skibina, Olga; Solaro, Claudio; Karabudak, Rana; VAN WIJMEERSCH, Bart; Csepany, Tunde; Spitaleri, Daniele; Vucic, Steve; Casey, Romain; Debouverie, Marc; Edan, Gilles; Ciron, Jonathan; Ruet, Aurelie; Seze, Jerome D.; Maillart, Elisabeth; Zephir, Helene; Labauge, Pierre; Defer, Gilles; Lebrun, Christine; Moreau, Thibault; Clavelou, Pierre; Pelletier, Jean; Stankoff, Bruno; Gout, Olivier; Thouvenot, Eric; Heinzlef, Olivier; Al-Khedr, Abdullatif; Bourre, Bertrand; Casez, Olivier; Cabre, Philippe; Montcuquet, Alexis; Wahab, Abir; Camdessanche, Jean-Philippe; Marousset, Aude; Patry, Ivania; Hankiewicz, Karolina; Pottier, Corinne; Maubeuge, Nicolas; Labeyrie, Celine; Nifle, Chantal; Leray, Emmanuelle; Laplaud, David A.; Butzkueven, Helmut; Kalincik, Tomas; Vukusic, Sandra; Magyari, Melinda; Berger, Eric; Sharmin, Sifat | Journal Contribution | A1 |
| 13 | 2021 | Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression | DE BROUWER, Edward; BECKER, Thijs; Moreau, Yves; Havrdova, Eva; Trojano, Maria; Eichau, Sara; Ozakbas, Serkan; Onofrj, Marco; Grammond, Pierre; Kuhle, Jens; Kappos, Ludwig; Sola, Patrizia; Cartechini, Elisabetta; Lechner-Scott, Jeannette; Alroughani, Raed; Gerlach, Oliver; Kalincik, Tomas; Granella, Franco; Grand'maison, Francois; Bergamaschi, Roberto; José Sá, Maria; VAN WIJMEERSCH, Bart; Soysal, Aysun; Sanchez-Menoyo, Jose; Solaro, Claudio; Boz, Cavit; Iuliano, Gerardo; Buzzard, Katherine; Aguera-Morales, Eduardo; Terzi, Murat; Trivio, Tamara; Spitaleri, Daniele; Van Pesch, Vincent; Shaygannejad, Vahid; Moore, Fraser; Oreja-Guevara, Celia; Maimone, Davide; Gouider, Riadh; Csepany, Tunde; Ramo-Tello, Cristina; PEETERS, Liesbet | Journal Contribution | A1 |
| 14 | 2021 | Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts | Sharmin, Sifat; Lefort, Mathilde; Andersen, Johanna Balslev; Leray, Emmanuelle; Horakova, Dana; Havrdova, Eva Kubala; Alroughani, Raed; Izquierdo, Guillermo; Ozakbas, Serkan; Patti, Francesco; Onofrj, Marco; Lugaresi, Alessandra; Terzi, Murat; Grammond, Pierre; Grand'Maison, Francois; Yamout, Bassem; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Boz, Cavit; Trojano, Maria; McCombe, Pamela; Slee, Mark; Lechner-Scott, Jeannette; Turkoglu, Recai; Sola, Patrizia; Ferraro, Diana; Granella, Franco; Prevost, Julie; Maimone, Davide; Skibina, Olga; Buzzard, Katherine; Van der Walt, Anneke; VAN WIJMEERSCH, Bart; Csepany, Tunde; Spitaleri, Daniele; Vucic, Steve; Casey, Romain; Debouverie, Marc; Edan, Gilles; Ciron, Jonathan; Ruet, Aurelie; De Seze, Jerome; Maillart, Elisabeth; Zephir, Helene; Labauge, Pierre; Defer, Gilles; Lebrun-Frenay, Christine; Moreau, Thibault; Berger, Eric; Clavelou, Pierre; Pelletier, Jean; Stankoff, Bruno; Gout, Olivier; Thouvenot, Eric; Heinzlef, Olivier; Al-Khedr, Abullatif; Bourre, Bertrand; Casez, Olivier; Cabre, Philippe; Montcuquet, Alexis; Wahab, Abir; Camdessanche, Jean-Philippe; Maurousset, Aude; Patry, Ivania; Hankiewicz, Karolina; Pottier, Corinne; Maubeuge, Nicolas; Labeyrie, Celine; Nifle, Chantal; Laplaud, David; Koch-Henriksen, Niels; Sellebjerg, Finn Thorup; Soerensen, Per Soelberg; Pfleger, Claudia Christina; Rasmussen, Peter Vestergaard; Jensen, Michael Broksgaard; Frederiksen, Jette Lautrup; Bramow, Stephan; Mathiesen, Henrik Kahr; Schreiber, Karen Ingrid; Magyari, Melinda; Vukusic, Sandra; Butzkueven, Helmut; Kalincik, Tomas | Journal Contribution | A1 |
| 15 | 2021 | IgD-CD27-double negative (DN) B cells of multiple sclerosis patients are mature memory cells that can migrate towards pro-inflammatory chemokines | BECKERS, Lien; MONTES DIAZ, Gwendoline; Maria Villar, Luisa; VAN WIJMEERSCH, Bart; POPESCU, Veronica; SOMERS, Veerle; FRAUSSEN, Judith | Journal Contribution | M |
| 16 | 2021 | Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score | Kunchok, Amy; Lechner-Scott, Jeannette; Granella, Franco; Trojano, Maria; Alroughani, Raed; Sola, Patrizia; Ferraro, Diana; Lugaresi, Alessandra; Onofrj, Marco; Ozakbas, Serkan; Izquierdo, Guillermo; Grammond, Pierre; Luis Sanchez-Menoyo, Jose; VAN WIJMEERSCH, Bart; Boz, Cavit; Pucci, Eugenio; McCombe, Pamela; Grand'Maison, Francois; Spitaleri, Daniele; Vucic, Steve; Hupperts, Raymond; Jokubaitis, Vilija; Sormani, Maria Pia; Butzkueven, Helmut; Kalincik, Tomas | Journal Contribution | A1 |
| 17 | 2021 | Multiple Sclerosis Data Alliance - A global multi-stakeholder collaboration to scale-up real world data research | PEETERS, Liesbet; PARCIAK, Tina; Kalra, Dipak; Moreau, Yves; Kasilingam, Elisabeth; Galen, Pieter van; Thalheim, Christoph; Uitdehaag, Bernard; Vermersch, Patrick; HELLINGS, Niels; STINISSEN, Piet; VAN WIJMEERSCH, Bart; Ardeshirdavani, Amin; PIRMANI, Ashkan; Brouwer, Edward De; Bauer, Christian Robert; Krefting, Dagmar; Ribbe, Stephanie; Middleton, Rod; Stahmann, Alexander; Comi, Giancarlo | Journal Contribution | A1 |
| 18 | 2021 | Determinants of therapeutic lag in multiple sclerosis | Roos, I; Leray, E; Frascoli, F; Casey, R; Brown, JWL; Horakova, D; Havrdova, EK; Debouverie, M; Trojano, M; Patti, F; Izquierdo, G; Eichau, S; Edan, G; Prat, A; Girard, M; Duquette, P; Onofrj, M; Lugaresi, A; Grammond, P; Ciron, J; Ruet, A; Ozakbas, S; De Seze, J; Louapre, C; Zephir, H; Sa, MJ; Sola, P; Ferraro, D; Labauge, P; Defer, G; Bergamaschi, R; Lebrun-Frenay, C; Boz, C; Cartechini, E; Moreau, T; Laplaud, D; Lechner-Scott, J; Grand'Maison, F; Gerlach, O; Terzi, M; Granella, F; Alroughani, R; Iuliano, G; Van Pesch, V; VAN WIJMEERSCH, Bart; La Spitaleri, D; Soysal, A; Berger, E.; Prevost, J; Aguera-Morales, E; McCombe, P; Trivino, TC; Clavelou, P; Pelletier, J; Turkoglu, R; Stankoff, B; Gout, O; Thouvenot, E; Heinzlef, O; Sidhom, Y; Gouider, R; Csepany, T; Bourre, B; Al Khedr, A; Casez, O; Cabre, P; Montcuquet, A; Wahab, A; Camdessanche, JP; Maurousset, A; Patry, I; Hankiewicz, K; Pottier, C; Maubeuge, N; Labeyrie, C; Nifle, C; Coles, A; Malpas, CB; Vukusic, S; Butzkueven, H; Kalincik, T | Journal Contribution | A1 |
| 19 | 2021 | Application of step and beat alignment approaches and its effect on gait in progressive multiple sclerosis with severe cerebellar ataxia: A proof of concept case study | MOUMDJIAN, Lousin; Moens, Bart; VAN WIJMEERSCH, Bart; Leman, Marc; FEYS, Peter | Journal Contribution | A1 |
| 20 | 2021 | Characterisation of the innate and adaptive immune system after ocrelizumab treatment in multiple sclerosis | BECKERS, Lien; BAETEN, Paulien; SWINNEN, Dries; HAMAD, Ibrahim; Tavernier, S.; VAN WIJMEERSCH, Bart; POPESCU, Veronica; KLEINEWIETFELD, Markus; BROUX, Bieke; FRAUSSEN, Judith; SOMERS, Veerle | Journal Contribution | M |
| 21 | 2021 | Differential effects and discriminative validity of motor and cognitive tasks varying in difficulty on cognitive–motor interference in persons with multiple sclerosis | VELDKAMP, Renee; Kalron, Alon; BAERT, Ilse; Hamalainen, Paivi; Tacchino, Andrea; D'HOOGE, Mieke; GIFFROY, Xavier; VAN GEEL, Fanny; RAATS, Joke; CONINX, Karin; VAN WIJMEERSCH, Bart; FEYS, Peter | Journal Contribution | A1 |
| 22 | 2021 | The Multiple Sclerosis Data Alliance Catalogue; Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources | GEYS, Lotte; PARCIAK, Tina; PIRMANI, Ashkan; McBurney, Robert; Schmidt, Hollie; Malbaša, Tanja; Ziemssen, Tjalf; Bergmann, Arnfin; Rojas, Juan I.; Cristiano, Edgardo; García-Merino, Juan Antonio; Fernández, Óscar; Kuhle, Jens; Gobbi, Claudio; Delmas, Amber; Simpson-Yap, Steve; Nag, Nupur; Yamout, Bassem; Steinemann, Nina; Seeldrayers, Pierrette; Dubois, Bénédicte; van der Mei, Ingrid; Stahmann, Alexander; Drulovic, Jelena; Pekmezovic, Tatjana; Brola, Waldemar; Tintore, Mar; Kalkers, Nynke; Ivanov, Rumen; Zakaria, Magd; Naseer, Maged Abdel; Van Hecke, Wim; Grigoriadis, Nikolaos; Boziki, Marina; Carra, Adriana; Pawlak, Mikolaj A.; Dobson, Ruth; Hellwig, Kerstin; Gallagher, Arlene; Leocani, Letizia; Dalla Costa, Gloria; de Carvalho Sousa, Nise Alessandra; VAN WIJMEERSCH, Bart; PEETERS, Liesbet | Journal Contribution | A1 |
| 23 | 2020 | Alemtuzumab Improves Clinical and MRI Disease Activity Outcomes, Including Slowing of Brain Volume Loss, in RRMS Patients Over 8 Years: CARE-MS I Follow-up (TOPAZ Study) | Hartung, H-P; Comi, G.; Arnold, D. L.; Boyko, A. N.; Havrdova, E. K.; Inshasi, J. S.; McCombe, P.; Nakamura, K.; Oreja-Guevara, C.; Pelletier, D.; Pozzilli, C.; Selmaj, K. W.; Scott, T. F.; Chung, L.; Daizadeh, N.; Afsar, S.; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 24 | 2020 | Efficacy/safety Of Ocrelizumab In Relapsing-remitting MS Patients With Suboptimal Response To Prior Disease-modifying Therapies (1-yr Interim Results) | Vermersch, P.; Eralinna, J.; Nicholas, R.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Buffels, R.; Wei, W.; Comi, G. | Journal Contribution | M |
| 25 | 2020 | One-Year Interim Analysis of Health-Related Quality of Life in RRMS Patients Treated With Alemtuzumab in a Real-world Clinical Setting (LemQoL Study) | VAN WIJMEERSCH, Bart; Harrower, T.; Hobart, J.; Kizlaitiene, R.; Marfia, G. A.; Patti, F.; Pearson, O. R.; Van Pesch, V.; Vanderdonckt, P.; Vecsei, L.; Shor, S.; Achiron, A. | Journal Contribution | M |
| 26 | 2020 | Alemtuzumab Outcomes Over 9 Years in RRMS Patients With Highly Active Disease From CARE-MS I and II (TOPAZ) | Ziemssen, T.; Bass, A. D.; Berkovich, R.; Eichau, S.; Hobart, J.; Hunter, S. F.; Limmroth, V.; Pelletier, D.; Pozzilli, C.; Schippling, S.; Singer, B. A.; Sousa, L.; Traboulsee, A.; Uittlehaag, B. M. J.; VAN WIJMEERSCH, Bart; Poole, E. M.; Choudhry, Z.; Geertsen, S.; Daizadeh, N.; Comi, G. | Journal Contribution | M |
| 27 | 2020 | Disability accrual in primary-progressive & secondary-progressive multiple sclerosis | Harding-Forrester, S.; Roos, I.; Sharmin, S; Diouf, I.; Malpas, C.; Nguyen, A. -L.; Moradi, N.; Horakova, D.; Havrdova, E. Kubala; Patti, F.; Izquierdo, G.; Eichau, S.; Prat, A.; Girard, M.; Duquette, P.; Onofrj, M.; Lugaresi, A.; Grand'Maison, F.; Weinstock-Guttman, B.; Amato, M. P.; Grammond, P.; Gerlach, O.; Ozakbas, S.; Sola, P.; Ferraro, D.; Butzkueven, H.; Lechner-Scott, J.; Boz, C.; Alroughani, R.; Van Pesch, V.; Cartechini, E.; Terzi, M.; Maimone, D.; Ramo-Tello, C.; Spitaleri, D.; Kappos, L.; Yamout, B.; Sa, M.; Slee, M.; Blanco, Y.; Bergamaschi, R.; Butler, E.; Iuliano, G.; Granella, F.; Sidhom, Y.; Gouider, R.; Ampapa, R.; VAN WIJMEERSCH, Bart; Karabudak, R.; Prevost, J.; Sanchez-Menoyo, J. L.; Verheul, F.; Mccombe, P.; Castillo-Trivino, T.; Macdonell, R.; Altintas, A.; Laureys, G.; Van Hijfte, L.; Van der Walt, A.; Vucic, S.; Turkoglu, R.; Barnett, M.; Cristiano, E.; Zakaria, M.; Shaygannejad, V.; Hodgkinson, S.; Soysal, A.; Kalincik, T. | Journal Contribution | M |
| 28 | 2020 | Ocrelizumab phase iiib efficacy from casting: 2-year neda (mri re-baselined) subgroup rates in rrms patients with a suboptimal response to prior dmts | Wiendl, H.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wuerfel, J.; Buffels, R.; Kadner, K.; Kuenzel, T.; Vermersch, P. | Journal Contribution | M |
| 29 | 2020 | Delay from treatment start to full effect of immunotherapies for multiple sclerosis | Roos, Izanne; Leray, Emmanuelle; Frascoli, Federico; Casey, Romain; Brown, J. William L.; Horakova, Dana; Havrdova, Eva K.; Trojano, Maria; Patti, Francesco; Izquierdo, Guillermo; Eichau, Sara; Onofrj, Marco; Lugaresi, Alessandra; Prat, Alexandre; Girard, Marc; Grammond, Pierre; Sola, Patrizia; Ferraro, Diana; Ozakbas, Serkan; Bergamaschi, Roberto; Sa, Maria Jose; Cartechini, Elisabetta; Boz, Cavit; Granella, Franco; Hupperts, Raymond; Terzi, Murat; Lechner-Scott, Jeannette; Spitaleri, Daniele; Van Pesch, Vincent; Soysal, Aysun; Olascoaga, Javier; Prevost, Julie; Aguera-Morales, Eduardo; Slee, Mark; Csepany, Tunde; Turkoglu, Recai; Sidhom, Youssef; Gouider, Riadh; VAN WIJMEERSCH, Bart; McCombe, Pamela; Macdonell, Richard; Coles, Alasdair; Malpas, Charles B.; Butzkueven, Helmut; Vukusic, Sandra; Kalincik, Tomas | Journal Contribution | A1 |
| 30 | 2020 | CNS delivery of anti-CD52 antibodies modestly reduces disease severity in an animal model for multiple sclerosis | BOGIE, Jeroen; GRAJCHEN, Elien; WOUTERS, Elien; BROUX, Bieke; STINISSEN, Piet; VAN WIJMEERSCH, Bart; HENDRIKS, Jerome | Journal Contribution | A1 |
| 31 | 2020 | The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective | Alroughani, Raed; VAN WIJMEERSCH, Bart; Al Khaboori, Jabber; Alsharoqi, Isa Ahmed; Ahmed, Samar F.; Hassan, Ali; Inshasi, Jihad; Krieger, Derk W.; Shakra, Mustafa; Shatila, Ahmed Osman; Szolics, Miklos; Khallaf, Mohamed; Ezzat, Aly | Journal Contribution | A1 |
Loading...
5
0
5
0
false